XML 39 R32.htm IDEA: XBRL DOCUMENT
v3.25.3

Revenue and Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Revenue from Contract with Customer [Abstract] |
Schedule of Net Revenue by Organ and Country | The Company disaggregates revenue from contracts with customers related to OCS transplant by organ type and geographical area as it believes this presentation best depicts how the nature, amount, timing and uncertainty of the Company’s revenue and cash flows are affected by economic factors, as shown below (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
OCS transplant revenue by country by organ(1)(2): |  |  |  |  |  |  |  |  |  |  |  |
United States |  |  |  |  |  |  |  |  |  |  |  |
Lung total revenue |  | $ | 3,725 |  |  | $ | 3,726 |  |  | $ | 11,515 |  |  | $ | 12,675 |
Heart total revenue |  |  | 27,401 |  |  |  | 24,525 |  |  |  | 85,838 |  |  |  | 71,922 |
Liver total revenue |  |  | 107,883 |  |  |  | 76,671 |  |  |  | 332,460 |  |  |  | 220,636 |
Total United States OCS transplant revenue |  |  | 139,009 |  |  |  | 104,922 |  |  |  | 429,813 |  |  |  | 305,233 |
All other countries |  |  |  |  |  |  |  |  |  |  |  |
Lung revenue |  |  | 385 |  |  |  | 182 |  |  |  | 1,181 |  |  |  | 1,590 |
Heart revenue |  |  | 3,187 |  |  |  | 2,401 |  |  |  | 10,232 |  |  |  | 9,800 |
Liver revenue |  |  | 58 |  |  |  | — |  |  |  | 442 |  |  |  | — |
Total all other countries OCS transplant revenue |  |  | 3,630 |  |  |  | 2,583 |  |  |  | 11,855 |  |  |  | 11,390 |
Total OCS transplant revenue |  | $ | 142,639 |  |  | $ | 107,505 |  |  | $ | 441,668 |  |  | $ | 316,623 |
(1) Revenue by country is categorized based on the location of the end customer. Total OCS transplant revenue includes product and service revenue. (2) Service revenue unrelated to OCS transplant, which was $1.2 million and $3.1 million for the three and nine months ended September 30, 2025, respectively, and $1.3 million and $3.3 million for the three and nine months ended September 30, 2024, respectively, is not included in this table.
Summary of Significant Segment Expenses | Significant segment expenses, as provided to the CODM, are presented below (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Total revenue |  | $ | 143,823 |  |  | $ | 108,761 |  |  | $ | 444,730 |  |  | $ | 319,916 |
Less: |  |  |  |  |  |  |  |  |  |  |  |
Cost of net product revenue |  |  | 18,687 |  |  |  | 13,246 |  |  |  | 54,420 |  |  |  | 41,800 |
Cost of service revenue |  |  | 40,561 |  |  |  | 34,670 |  |  |  | 120,918 |  |  |  | 88,048 |
Research, development and clinical trials: |  |  |  |  |  |  |  |  |  |  |  |
Personnel related (including stock-based compensation expense) |  |  | 6,444 |  |  |  | 5,462 |  |  |  | 18,660 |  |  |  | 16,204 |
Laboratory supplies and research materials |  |  | 2,992 |  |  |  | 3,085 |  |  |  | 13,154 |  |  |  | 9,332 |
Consulting and third-party services |  |  | 3,432 |  |  |  | 3,859 |  |  |  | 9,907 |  |  |  | 8,504 |
Clinical trials costs |  |  | 278 |  |  |  | 182 |  |  |  | 626 |  |  |  | 452 |
Facility related and other |  |  | 2,114 |  |  |  | 1,678 |  |  |  | 6,007 |  |  |  | 5,012 |
Selling, general and administrative: |  |  |  |  |  |  |  |  |  |  |  |
Personnel related (including stock-based compensation expense) |  |  | 29,234 |  |  |  | 28,188 |  |  |  | 84,212 |  |  |  | 79,567 |
Professional and consultant fees |  |  | 6,395 |  |  |  | 4,086 |  |  |  | 19,649 |  |  |  | 12,636 |
NOP support |  |  | 1,173 |  |  |  | 3,558 |  |  |  | 5,511 |  |  |  | 9,101 |
Tradeshows and conferences |  |  | 1,076 |  |  |  | 353 |  |  |  | 3,051 |  |  |  | 3,218 |
Facility related and other |  |  | 8,137 |  |  |  | 6,471 |  |  |  | 21,305 |  |  |  | 17,190 |
Other segment items(1) |  |  | (1,019 | ) |  |  | (293 | ) |  |  | 2,402 |  |  |  | 245 |
Net income |  | $ | 24,319 |  |  | $ | 4,216 |  |  | $ | 84,908 |  |  | $ | 28,607 |
(1) Other segment items include interest income, interest expense, foreign currency exchange gains and losses and income taxes. See the condensed consolidated financial statements for other financial information regarding the Company’s operating segment.

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration